Concepedia

R Weaver

RW

4

Publications

142

Citations

4

H-Index

1999

Active since

Affiliations

Sarah Cannon(Current)

Eli Lilly (United States)

Florida Cancer Specialists & Research Institute

R Weaver is an author at Sarah Cannon specializing in cancer therapeutics, cell biology, and medicine.

Top concepts

Publications per year

1999–2017

4

Publications

4

A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer

Ravi Salgia, John R. Stille, R Weaver et al. · Lung Cancer · 2017 · 74 citations

, , +6

Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study

Ravi Salgia, R Weaver, Michael McCleod et al. · Investigational New Drugs · 2017 · 41 citations · Full text

Abstract P6-10-01: A randomized phase 2 study of the antibody-drug conjugate CDX-011 in advanced GPNMB-overexpressing breast cancer: The EMERGE study

DA Yardley, R Weaver, ME Melisko et al. · Cancer Research · 2012 · 17 citations

, , +20

Trends in postdoctoral dental education

R Weaver · Journal of Dental Education · 1999 · 10 citations

, ,

Rows per page

1–4 of 4